Dr. Al-Hareth M. Al-Khater | Hamad Bin Khalifa University
Hamad Bin Khalifa University

Scientific Advisory Committee BIOGRAPHIES

Dr. Al-Hareth M. Al-Khater

Dr. Al-Hareth M. Al-Khater

Member of Scientific Advisory Committee
Qatar Biomedical Research Institute


Dr. Al-Hareth M. Al-Khater is a Senior Consultant Physician and the Deputy Medical Director for Clinical Affairs, National Center for Cancer Care and Research (NCCCR).

Dr. Al-Khater was granted a Qatari national medical scholarship and obtained his medical degree at the Royal College of Surgeons in Ireland. He then joined Hamad Medical Corporation (HMC), Doha, Qatar, where he did his internship and internal medicine residency training before obtaining a national medical sub-specialty scholarship. He completed his internal medicine residency, hematology, and medical oncology fellowship training at the University of Missouri-Columbia, working at the University Hospital, the Harry S. Truman Memorial Veterans’ Hospital and Ellis Fischel Cancer Center. He has obtained the American Board certification in internal medicine, hematology, and medical oncology.

Dr. Al-Khater is currently a Senior Consultant Medical Oncologist, Deputy Medical Director for Clinical Affairs at the NCCCR, and Chair of the Healthcare Ethics Committee at HMC, Doha, Qatar. He is also a Medical Advisor for the National Cancer Program in the Ministry of Public Health, Qatar, and he represents the State of Qatar as a member of the Governing Council for the International Agency for Research on Cancer (IARC), Lyon, France. He has participated in many institutional, national, and international committees including being a member of the Qatar National Research Ethics Committee, member of the Qatar State Awards Trustees' Committee, member of the Executive Committee for the Board of Regents of Qatar University, member of the Advisory Committee for the Gulf Center for Cancer Control and Prevention, Riyadh, Saudi Arabia, and a member of the Scientific Council for the IARC. His main interests are urological cancers and healthcare ethics at the end of life.